1. Home
  2. Analysis
  3. Glutamine
  4. Visual-impairment
Please log in to access this page.

Glutamine and Visual impairment - a phase IV clinical study of FDA data

Summary:

Visual impairment is reported as a side effect among people who take Glutamine (glutamine), especially for people who are female, 50-59 old, also take Biotin, and have Metastases to bone.

The phase IV clinical study analyzes which people have Visual impairment when taking Glutamine. It is created by eHealthMe based on reports of 2,558 people who have side effects when taking Glutamine from the FDA, and is updated regularly.

What is Glutamine?

Glutamine has active ingredients of glutamine. It is often used in muscle building therapy. eHealthMe is studying from 2,705 Glutamine users. Check the latest studies of Glutamine.

What is Visual impairment?

Visual impairment is found to be associated with 2,256 drugs and 2,335 conditions by eHealthMe. Check the latest studies of Visual impairment.

On Jul, 23, 2026

2,558 people reported to have side effects when taking Glutamine.
Among them, 31 people (1.21%) have Visual impairment.

Could Glutamine cause Visual impairment?

Among these 31 people:

What is the gender of people who have Visual impairment when taking Glutamine? *

  • female: 80.65 %
  • male: 19.35 %

What is the age of people who have Visual impairment when taking Glutamine? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 7.41 %
  • 30-39: 0.0 %
  • 40-49: 11.11 %
  • 50-59: 44.44 %
  • 60+: 37.04 %

What are other drugs people take besides Glutamine? *

  1. Cymbalta: 17 people, 54.84%
  2. Biotin: 17 people, 54.84%
  3. Celebrex: 15 people, 48.39%
  4. Coq10: 15 people, 48.39%
  5. Nasonex: 15 people, 48.39%
  6. Prilosec: 15 people, 48.39%
  7. Celexa: 15 people, 48.39%
  8. Magnesium: 14 people, 45.16%
  9. Selenium: 14 people, 45.16%
  10. Desoxyn: 14 people, 45.16%

What are other side effects people have besides Visual impairment? *

  1. Abdominal Pain Upper: 20 people, 64.52%
  2. Back Pain: 19 people, 61.29%
  3. Pain: 18 people, 58.06%
  4. Chest Pain: 18 people, 58.06%
  5. Fluid Retention (an abnormal accumulation of fluid in the blood): 18 people, 58.06%
  6. Weight Increased: 17 people, 54.84%
  7. Diarrhea: 17 people, 54.84%
  8. Indigestion: 17 people, 54.84%
  9. Tinnitus (a ringing in the ears): 16 people, 51.61%
  10. Headache (pain in head): 16 people, 51.61%

What are the existing conditions these people have? *

  1. Metastases To Bone (cancer spreads to bone): 14 people, 45.16%
  2. Stress And Anxiety: 4 people, 12.90%
  3. Pain: 4 people, 12.90%
  4. Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 3 people, 9.68%
  5. Blood Iron Decreased: 3 people, 9.68%
  6. Functional Gastrointestinal Disorder (functional problem in separate organs of gastrointestinal system): 3 people, 9.68%
  7. Endometrial Cancer: 3 people, 9.68%
  8. Urination - Painful: 3 people, 9.68%
  9. Muscle Spasms (muscle contraction): 3 people, 9.68%
  10. Nausea (feeling of having an urge to vomit): 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Glutamine and have Visual impairment?

- Check whether Visual impairment is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Glutamine:

Visual impairment treatments and more:

How severe was Visual impairment and when was it recovered:

Expand to all the drugs that have ingredients of glutamine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Glutamine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual impairment:

Browse all the conditions that are associated with Visual impairment:

How the study uses the data?

The study uses data from the FDA. It is based on glutamine (the active ingredients of Glutamine) and Glutamine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.